 Allergan, a unit of AbbVie Inc NYSE: ABBV, has announced new data, including the full results from the Phase 3 GEMINI 1 study of AGN-190584 pilocarpine 1.25 ophthalmic solution for presbyopia. Multiple data presentations were made at the 2021 ASCRS Annual Meeting. 